Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, Merseyside, UK.
Rinda Ubuzima, Kigali, Rwanda.
BMJ Open. 2020 May 19;10(5):e031819. doi: 10.1136/bmjopen-2019-031819.
To evaluate adherence and acceptability of intermittent vaginal probiotic or antibiotic use to prevent bacterial vaginosis (BV) recurrence.
Repeated adherence and acceptability assessments using mixed methods within a pilot randomised controlled trial.
Research clinic in Kigali, Rwanda.
Rwandan women with high sexual risk.
Women diagnosed with BV and/or trichomoniasis were randomised to four groups (n=17 each) after completing metronidazole treatment: behavioural counselling only, or behavioural counselling plus 2-month intermittent use of oral metronidazole, Ecologic Femi+ (EF+) vaginal capsule or Gynophilus LP (GynLP) vaginal tablet.
Adherence and acceptability were assessed by structured face-to-face interviews, semi-structured focus group discussions and in-depth interviews, daily diaries and counting of used/unused study products in randomised women (n=68). Vaginal infection knowledge was assessed by structured face-to-face interviews in randomised women and women attending recruitment sessions (n=131).
Most women (93%) were sex workers, 99.2% were unfamiliar with BV and none had ever used probiotics. All probiotic users (n=32) reported that insertion became easier over time. Triangulated adherence data showed that 17/17 EF+ users and 13/16 GynLP users used ≥80% of required doses (Fisher's exact p=0.103). Younger age (p=0.076), asking many questions at enrolment (p=0.116), having menses (p=0.104) and reporting urogenital symptoms (p=0.103) were non-significantly associated with lower perfect adherence. Women believed that the probiotics reduced BV recurrence, but reported that partners were sometimes unsupportive of study participation. Self-reported vaginal washing practices decreased during follow-up, but sexual risk behaviours did not. Most women (12/15) with an uncircumcised steady partner discussed penile hygiene with him, but many women found this difficult, especially with male clients.
High-risk women require education about vaginal infections. Vaginal probiotic acceptability and adherence were high in this cohort. Our results can be used to inform future product development and to fine-tune counselling messages in prevention programmes.
NCT02459665.
评估间歇性阴道益生菌或抗生素预防细菌性阴道病(BV)复发的依从性和可接受性。
在一项试点随机对照试验中,使用混合方法进行反复的依从性和可接受性评估。
卢旺达基加利的研究诊所。
性风险较高的卢旺达妇女。
在完成甲硝唑治疗后,将诊断为 BV 和/或滴虫病的妇女随机分为四组(每组 17 人):仅行为咨询,或行为咨询加 2 个月间歇性口服甲硝唑、Ecologic Femi+(EF+)阴道胶囊或 Gynophilus LP(GynLP)阴道片。
在随机分组的妇女(n=68)中,通过结构化面对面访谈、半结构化焦点小组讨论和深入访谈、每日日记和计算使用/未使用的研究产品来评估依从性和可接受性。在随机分组的妇女和参加招募会议的妇女(n=131)中,通过结构化面对面访谈评估阴道感染知识。
大多数妇女(93%)为性工作者,99.2%对 BV 不熟悉,且无人曾使用过益生菌。所有益生菌使用者(n=32)均报告说,随着时间的推移,插入变得更容易。三角化的依从性数据显示,17/17 名 EF+使用者和 13/16 名 GynLP 使用者使用了≥80%所需剂量(Fisher 确切检验 p=0.103)。年轻(p=0.076)、入组时提出许多问题(p=0.116)、经期(p=0.104)和报告泌尿生殖症状(p=0.103)与完全依从性较低无显著相关性。妇女认为益生菌减少了 BV 的复发,但报告说伴侣有时不支持参与研究。在随访期间,自我报告的阴道冲洗行为减少,但性风险行为没有减少。大多数(12/15)有未割包皮的稳定伴侣的妇女与他讨论了阴茎卫生问题,但许多妇女发现这很困难,尤其是对男性客户。
高危妇女需要接受阴道感染方面的教育。在本队列中,阴道益生菌的可接受性和依从性较高。我们的研究结果可用于指导未来产品的开发,并微调预防计划中的咨询信息。
NCT02459665。